Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer, lacking targeted therapies due to its molecular characteristics. Tumor-associated ...

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly ...

Interestingly, clinical benefit with T-DXd was observed in approximately one-third ... et al "Real-world clinical outcomes with sacituzumab govitecan in metastatic triple-negative breast cancer ...

As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

Yoanna Pumpalova, MD People infected with human immunodeficiency virus (HIV) have a substantially higher risk of certain types of cancer -Kaposi ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr. Siddhartha Mukherjee, an oncologist.

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

The Royal Surrey Cancer Centre was reopened by two-time Paralympic gold medallist Erin Kennedy on Tuesday following a £6m ...

Zelenirstat, a cancer-fighting pill made in Alberta, may have the power to save lives — but millions more in clinical trial funding and donations are needed to make it a reality.